Evidence map›Paper›PMID 33594368›Full record

ArticlebioRxiv : the preprint server for biology2021

Disruption of nuclear architecture as a cause of COVID-19 induced anosmia.

Marianna Zazhytska, Albana Kodra, Daisy A Hoagland, John F Fullard, Hani Shayya, Arina Omer, Stuart Firestein, Qizhi Gong, Peter D Canoll, James E Goldman and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Marianna ZazhytskaMortimer B. Zuckerman Mind, Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
Albana KodraMortimer B. Zuckerman Mind, Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
Daisy A HoaglandDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA.
John F FullardPamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA.
Hani ShayyaMortimer B. Zuckerman Mind, Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
Arina OmerBaylor Genetics, 2450 Holcombe Blvd, Houston, TX, 77021, USA.
Stuart FiresteinDepartment of Biological Sciences, Columbia University New York, NY, 10027, USA.
Qizhi GongDepartment of Cell Biology and Human Anatomy, School of Medicine, University of California at Davis, Davis, CA 95616, USA.
Peter D CanollDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
James E GoldmanDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Panos RoussosPamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA.
Benjamin R tenOeverDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA.
Jonathan B OverdevestDepartment of Otolaryngology- Head and Neck Surgery, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Stavros LomvardasMortimer B. Zuckerman Mind, Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.

Funding

Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer DiseaseR01AG067025 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FINKBEINER, STEVEN M, HAROUTUNIAN, VAHRAM · 2019 to 2023
$11.8M
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer DiseaseR01AG065582 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAROUTUNIAN, VAHRAM, ROUSSOS, PANAGIOTIS · 2020 to 2024
$9.9M
PREDOCTORAL TRAINING GRANT IN HUMAN GENETICS &DEVELOPMET32GM007088 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SHEN, MICHAEL M. · 1985 to 2020
$7.1M
Olfactory receptor mRNAs as lncRNAs that regulate genomic interactionsR01DC018744 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stavros Lomvardas · 2020 to 2026
$3.7M
Interrogating genome folding trajectories in health and diseaseU01DA052783 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOMVARDAS, STAVROS · 2020 to 2024
$3.1M
The unfolded protein response as a mechanism for cellular identity in the developing olfactory systemF30DC019263 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHAYYA, HANI JOHN · 2020 to 2023
$191k
NIA NIH HHS R01 AG065582NIA NIH HHS R01 AG067025NIDA NIH HHS U01 DA052783NIDCD NIH HHS F30 DC019263NIDCD NIH HHS R01 DC018744NIGMS NIH HHS T32 GM007088
6 · The paper itself

Abstract

Olfaction relies on a coordinated partnership between odorant flow and neuronal communication. Disruption in our ability to detect odors, or anosmia, has emerged as a hallmark symptom of infection with SARS-CoV-2, yet the mechanism behind this abrupt sensory deficit remains elusive. Here, using molecular evaluation of human olfactory epithelium (OE) from subjects succumbing to COVID-19 and a hamster model of SARS-CoV-2 infection, we discovered widespread downregulation of olfactory receptors (ORs) as well as key components of their signaling pathway. OR downregulation likely represents a non-cell autonomous effect, since SARS-CoV-2 detection in OSNs is extremely rare both in human and hamster OEs. A likely explanation for the reduction of OR transcription is the striking reorganization of nuclear architecture observed in the OSN lineage, which disrupts multi-chromosomal compartments regulating OR expression in humans and hamsters. Our experiments uncover a novel molecular mechanism by which a virus with a very selective tropism can elicit persistent transcriptional changes in cells that evade it, contributing to the severity of COVID-19.

Identifiers

PMID33594368
PMCPMC7885920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.